Dinash Yanamadula, MD
Interventional Pain Medicine · Lawrenceville, NJNPI 1578507893
Payments from drug & device makers
Across 563 payments — averaging $28.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Averitas Pharma Inc.$4K
- Globus Medical$837
- Nevro Corp.$767
- Collegium Pharmaceutical, Inc.$670
- Biodelivery Sciences International, Inc.$491
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 277 | $7,281 |
| Averitas Pharma Inc. | 2 | $3,521 |
| Globus Medical | 18 | $837 |
| Nevro Corp. | 25 | $767 |
| Collegium Pharmaceutical, Inc. | 45 | $670 |
| Biodelivery Sciences International, Inc. | 46 | $491 |
| Si-bone, Inc. | 14 | $473 |
| Hikma Pharmaceuticals USA | 20 | $278 |
| Kowa Pharmaceuticals America, Inc. | 21 | $237 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $187 |
| Nalu Medical, Inc. | 2 | $181 |
| GRT US Holding, Inc. | 12 | $140 |
| Boston Scientific | 8 | $139 |
| Almatica Pharma LLC | 10 | $134 |
| Zimmer Biomet | 3 | $94 |
| Saluda Medical Americas, Inc. | 2 | $68 |
| Protega Pharmaceutials Inc | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 5 | $63 |
| Fidia Pharma USA Inc. | 5 | $63 |
| Pacira Therapeutics, Inc. | 4 | $61 |
| Pfizer | 4 | $56 |
| Johnson & Johnson | 3 | $47 |
| GSK | 3 | $46 |
| Forte Bio-pharma LLC | 2 | $35 |
| Lilly USA, LLC | 3 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Amgen | 2 | $26 |
| Bioventus LLC | 1 | $24 |
| Revance Therapeutics, Inc. | 1 | $21 |
| Medtronic | 1 | $20 |
| Vertex | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$16,142 in reported general payments places this provider in the 85th percentile of 82 interventional pain medicine providers in New Jersey.
See all interventional pain medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Lawrenceville
- Ali ValimahomedHolmdel$863K
- Youssef JosephsonWest Deptford$582K
- Saurabh DangEdgewater$271K
- Gabriele JasperBrick$126K
- Matthew LippChatham$67K
- Didier DemesminSomerset$61K
- Steve AydinFranklin Lakes$22K
- Kieran SlevinHainesport$21K
- John CoccaroToms River$17K
- Jay ShahColonia$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.